feed,title,long_url,short_url
Benzinga,Senhwa Announces the First Patient Enrolled in an Investigator Initiated Trial Of Silmitasertib as a Treatment for Patients with Severe COVID-19,https://www.benzinga.com/pressreleases/21/01/n19268393/senhwa-announces-the-first-patient-enrolled-in-an-investigator-initiated-trial-of-silmitasertib-as,https://j.mp/3sMta8n
